From the Daiichi Sankyo annual report:
" Phase III clinical trials were completed in Japan for the anti-influenza drug CS-8958. The Company plans to submit an application for regulatory approval during fiscal 2009."
Note they have a slightly different FY. Sounds like they are still positive on the trial.
- Forums
- ASX - By Stock
- BTA
- check this out
check this out
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)